Top U.S. Phlebotomy Supply Companies: Manufacturers and Distributors for Hospitals

Summary

• Hospitals in the United States commonly purchase phlebotomy and blood collection products from manufacturers such as BD, Greiner Bio-One, Sarstedt, Terumo, and FL Medical, as well as large distributors including Cardinal Health, McKesson, Medline, Owens & Minor, and Fisher Scientific.
• Product selection depends on clinical requirements, laboratory compatibility, regulatory compliance, supply continuity, total cost, and integration with automated specimen-processing systems.
• Hospitals should evaluate suppliers through contracts, product trials, quality documentation, inventory programs, and performance data rather than choosing solely on unit price.

Hospitals in the United States purchase phlebotomy and blood collection products through a complex supply network that includes original manufacturers, medical-surgical distributors, group purchasing organizations, laboratory suppliers, and regional dealers. The market covers much more than blood collection tubes. A typical hospital purchasing program may include needles, safety-engineered blood collection devices, syringes, tourniquets, tube holders, specimen transport bags, Blood Culture systems, lancets, capillary collection products, labels, sharps containers, and equipment for specimen handling.

Several companies have a major presence in this market. Becton, Dickinson and Company, commonly known as BD, is one of the best-known manufacturers of blood collection and specimen-management products. Greiner Bio-One, Sarstedt, Terumo Blood and Cell Technologies, and FL Medical also supply products used by hospitals and clinical laboratories. Large distributors such as Cardinal Health, McKesson, Medline, Owens & Minor, and Fisher Scientific often provide these products under direct contracts or through broader medical-surgical purchasing arrangements.

The most appropriate supplier for a hospital depends on the size and type of facility, its Laboratory Information System, existing tube and analyzer platforms, negotiated pricing, local inventory support, and the clinical environments in which products will be used. A large academic medical center may purchase directly from several manufacturers while also using a national distributor. A community hospital may rely primarily on a distributor that manages replenishment and consolidates thousands of products into fewer deliveries.

How the U.S. Phlebotomy Supply Market Is Organized

Phlebotomy supplies move through several channels before reaching a hospital. Manufacturers design and produce the products, distributors warehouse and transport them, and group purchasing organizations negotiate prices and contract terms for participating healthcare facilities. Some hospitals also maintain direct purchasing relationships with manufacturers for high-volume or specialized products.

Manufacturers

Manufacturers produce the blood collection devices and consumables used at the bedside and in the laboratory. They are responsible for product design, manufacturing controls, regulatory submissions, labeling, quality systems, and post-market monitoring. A manufacturer may sell directly to large health systems or use distributors for smaller accounts.

Medical-surgical distributors

Distributors are important because hospitals purchase thousands of different medical products. Instead of ordering every item separately from individual manufacturers, a hospital can place consolidated orders with a company such as Cardinal Health, McKesson, Medline, Owens & Minor, or Fisher Scientific. Distributors may offer warehousing, electronic ordering, inventory management, delivery scheduling, product substitution support, and contract administration.

Group purchasing organizations

Group purchasing organizations negotiate pricing and terms on behalf of hospitals and healthcare systems. Examples in the United States include Vizient, Premier, HealthTrust, and Intalere, although organizational structures and affiliations can change over time. A GPO does not necessarily manufacture or physically distribute products. Instead, it may establish contracts under which hospitals can buy eligible products at negotiated prices.

GPO participation is significant in the U.S. healthcare market. The Government Accountability Office has reported that hospitals often use GPO contracts to obtain supplies, while the proportion of purchases made through those contracts varies by health system and product category. In practice, a hospital may have access to a contracted manufacturer but still order the products through a distributor.

Major Manufacturers of Phlebotomy and Blood Collection Products

Becton, Dickinson and Company

BD is one of the most prominent suppliers of phlebotomy and blood collection products in the United States. Its portfolio includes evacuated blood collection tubes, blood collection needles, safety needles, tube holders, butterfly blood collection sets, syringes, Capillary Blood Collection products, Blood Culture collection products, and specimen-management accessories.

BD Vacutainer products are widely recognized in hospitals, outpatient laboratories, physician offices, and urgent care settings. The company’s product range is used for routine chemistry, hematology, coagulation, molecular testing, blood bank procedures, and other diagnostic applications. Many hospitals select BD products because of established laboratory workflows, broad product availability, and compatibility with common specimen-processing systems.

BD also supplies safety-engineered devices designed to reduce needlestick exposure. This is particularly important in the United States because the Occupational Safety and Health Administration’s Bloodborne Pathogens Standard requires employers to use engineering and work-practice controls and to consider safer medical devices where appropriate. The Needlestick Safety and Prevention Act strengthened these requirements by requiring employers to involve frontline healthcare workers in evaluating safer devices.

Hospitals evaluating BD products should review tube specifications, additive concentrations, minimum draw volumes, expiration dates, device activation methods, and analyzer compatibility. Changing tube brands can affect laboratory validation, staff training, Specimen Rejection rates, and electronic ordering systems, so product substitutions should be managed carefully.

Greiner Bio-One

Greiner Bio-One is another major supplier of blood collection and specimen-management products. Its VACUETTE product family includes evacuated blood collection tubes, safety blood collection sets, needles, holders, urine collection products, capillary systems, and accessories for preanalytical laboratory work.

Greiner Bio-One products are used by hospitals, reference laboratories, outpatient draw centers, and physician practices. The company competes in areas such as serum tubes, plasma tubes, coagulation tubes, Blood Culture collection, and special-purpose specimen containers. Its safety products are designed to support needlestick prevention and standardized blood collection techniques.

One advantage of a large blood collection manufacturer is the ability to supply a broad product family. Hospitals may prefer to standardize on one system to simplify staff education, reduce the number of stock-keeping units, and make tube identification easier. However, the laboratory must confirm that any new product produces acceptable results on its specific analyzers and testing platforms.

Sarstedt

Sarstedt supplies laboratory and medical products, including blood collection tubes, safety needles, blood collection sets, urine containers, specimen transport products, and preanalytical laboratory accessories. The company serves Healthcare Providers and laboratories in the United States through its domestic operations and distribution channels.

Sarstedt’s product range includes systems for venous and Capillary Blood Collection. Its products may be considered when a hospital wants alternatives to the two largest evacuated-tube brands or needs specialized specimen containers. Sarstedt also participates in broader laboratory automation and preanalytical Workflow markets, which can be relevant for high-volume laboratories.

Hospitals considering Sarstedt should examine tube dimensions, label placement, closure systems, additive performance, centrifugation requirements, and compatibility with automated lines. Preanalytical equipment is highly standardized but not universally interchangeable, so a product evaluation should involve phlebotomy staff, laboratory supervisors, quality personnel, and biomedical engineering representatives where appropriate.

Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies supplies products used in blood collection, blood component processing, apheresis, transfusion medicine, and cellular therapies. Its products are especially relevant to hospital blood banks, donor centers, transfusion services, and organizations that collect or process whole blood and blood components.

The company’s portfolio is broader than routine Venipuncture. Depending on the facility and contract, products may include blood bags, collection systems, apheresis disposables, processing equipment, and related blood-management products. Hospitals with a substantial transfusion service may purchase Terumo products directly or through specialized distributors.

Because blood collection and transfusion products involve highly controlled procedures, purchasing teams must review regulatory documentation, lot traceability, storage requirements, product shelf life, and emergency supply arrangements. Blood centers and hospital transfusion services typically place greater emphasis on continuity and validated processes than on small differences in unit pricing.

FL Medical

FL Medical produces laboratory and blood collection products, including evacuated tubes, specimen containers, needles, holders, and related accessories. The company is one of the alternatives available to U.S. hospitals and laboratories seeking additional sources for routine blood collection supplies.

Alternative manufacturers can be valuable during supply disruptions, allocation events, or contract changes. Nevertheless, a hospital should not switch brands solely because a product is temporarily less expensive. The laboratory must confirm that the tube additive, draw volume, material, closure, and transport conditions meet the requirements of each test system. Product validation and staff communication are essential before a new tube or collection device becomes part of routine use.

Other specialized manufacturers

Several other companies participate in narrower segments of the phlebotomy, specimen collection, and blood management market. These may include suppliers of Capillary Blood Collection products, Blood Culture systems, specimen transport materials, safety devices, and point-of-care collection kits.

Examples of companies that may appear in hospital sourcing projects include Sekisui Medical, QIAGEN for certain collection and molecular workflows, Copan for microbiology specimen collection, and manufacturers of specialty Blood Culture or molecular collection systems. The appropriate supplier depends on the intended test and the laboratory’s validated methodology. A product that is suitable for one test may not be approved or appropriate for another.

Major Distributors Serving U.S. Hospitals

Cardinal Health

Cardinal Health is one of the largest healthcare distributors in the United States. It supplies a broad range of medical-surgical products, including needles, syringes, blood collection tubes, specimen containers, gloves, dressings, and sharps-disposal products. Hospitals may purchase branded manufacturer products through Cardinal Health or use products from Cardinal Health’s own-label portfolio, depending on their contracts.

Cardinal Health’s value to hospitals is based on distribution scale and product consolidation. A hospital may reduce the number of individual purchase orders by sourcing routine phlebotomy items alongside other medical-surgical supplies. Distribution arrangements can also provide scheduled deliveries, usage reporting, and inventory services.

McKesson

McKesson distributes medical-surgical products to hospitals, integrated delivery networks, physician practices, laboratories, and other healthcare organizations. Its catalog commonly includes blood collection tubes, needles, safety devices, syringes, specimen bags, labels, and related laboratory supplies.

McKesson may support both national and regional healthcare accounts. Its purchasing systems can be particularly useful for facilities that want one distributor for routine consumables and access to multiple manufacturers. Buyers should review the distributor’s stock status, back-order procedures, substitution policies, delivery frequency, and customer-service escalation process.

Medline

Medline is a major manufacturer and distributor of medical supplies. Its product categories include phlebotomy supplies, laboratory products, safety needles, syringes, specimen containers, tourniquets, sharps containers, and other clinical consumables. Medline also sells products under its own brand and distributes products from other manufacturers.

Medline’s direct manufacturer role can simplify procurement for hospitals that want to standardize selected products. A health system may use Medline for routine supplies while maintaining separate contracts for specialized blood collection tubes or transfusion products. Hospitals should distinguish between a distributor’s private-label product and a branded product made by another company because specifications, packaging, labeling, and validation requirements may differ.

Owens & Minor

Owens & Minor provides healthcare logistics and distribution services in the United States. Its medical-surgical business supplies hospitals and other providers with a wide range of consumables, including products used in phlebotomy and specimen collection. Depending on the contract, the company may provide national distribution, private-label items, inventory-management programs, and supply-chain analytics.

Owens & Minor is relevant to hospitals seeking supply-chain consolidation. A distributor can help reduce the administrative burden associated with ordering individual products, but hospital buyers should monitor fill rates and back orders. A low quoted price may not be beneficial if the hospital frequently receives partial shipments or must purchase emergency replacements at higher prices.

Fisher Scientific

Fisher Scientific, part of Thermo Fisher Scientific, is a major laboratory and healthcare supplier. It provides blood collection tubes, needles, specimen containers, transport supplies, labels, laboratory plastics, personal protective equipment, and other products used in hospital laboratories and clinical settings.

Fisher Scientific is especially important for laboratories that purchase both routine phlebotomy products and specialized research or diagnostic materials. Its catalog can support central laboratories, pathology departments, microbiology departments, blood banks, and academic medical centers. Hospitals should confirm whether a product is intended for clinical diagnostic use, research use, or both, because labeling and regulatory status can differ.

Henry Schein and regional suppliers

Henry Schein is better known for dental and physician-office distribution but may also supply selected medical and laboratory products to outpatient practices, clinics, and smaller healthcare facilities. Regional medical distributors and laboratory dealers can also provide phlebotomy supplies to community hospitals, ambulatory centers, and independent laboratories.

Regional suppliers may offer responsive service and local inventory that is valuable during urgent shortages. Their catalogs may be narrower than those of national distributors, but they can sometimes provide more flexible delivery schedules or direct access to local account representatives. A hospital should evaluate financial stability, product traceability, recall communication, and emergency fulfillment capability before establishing a critical-supply relationship.

Products Hospitals Commonly Purchase

Phlebotomy purchasing programs usually include multiple product categories. The largest volume often comes from routine blood collection tubes and needles, but many low-cost accessories are essential to efficient and safe operations.

1. Evacuated blood collection tubes for serum, plasma, hematology, coagulation, glucose, trace-element, and molecular testing.
2. Safety needles, straight needles, butterfly sets, syringe-transfer devices, and tube holders.
3. Tourniquets, antiseptic wipes, gauze, adhesive bandages, gloves, and disposable protective equipment.
4. Blood Culture bottles and collection accessories for microbiology testing.
5. Capillary collection devices, lancets, microtainers, and heel-stick products.
6. Specimen bags, biohazard transport containers, absorbent materials, and pneumatic-tube-compatible packaging.
7. Labels, barcode printers, requisition materials, and bedside identification supplies.
8. Sharps containers and devices used for needle disposal and exposure prevention.
9. Blood bags, collection sets, and processing disposables for transfusion services and blood centers.

Product volumes vary considerably by facility. A large hospital may perform tens of thousands of blood collections each month, while an outpatient center may use a fraction of that volume but require a more limited selection of tube types. National U.S. hospital data from the American Hospital Association has consistently identified approximately 6,000 hospitals in the country, although the exact number varies according to the definition used and whether federal, specialty, and other facilities are included. This fragmented customer base creates opportunities for both national suppliers and specialized regional vendors.

Regulatory and Quality Considerations

Most blood collection devices used in hospitals are regulated medical devices. The U.S. Food and Drug Administration classifies and oversees many of these products, while the Centers for Medicare & Medicaid Services regulates laboratory quality through the Clinical Laboratory Improvement Amendments. The Occupational Safety and Health Administration addresses worker protection, including bloodborne pathogen exposure and needlestick prevention.

Purchasing teams should request current regulatory and quality documentation from suppliers. Depending on the product, this may include a 510(k) clearance or other FDA status, establishment registration information, certificates of analysis, sterility information, lot records, expiration data, instructions for use, and safety documentation.

Hospitals should also evaluate the supplier’s quality-management system. ISO 13485 certification can indicate that a manufacturer operates a medical-device quality system, although certification alone does not guarantee that every product or service will meet a hospital’s requirements. Buyers should review complaint handling, recall notification, change-control procedures, and the manufacturer’s process for communicating product changes.

Safety is a central purchasing criterion. According to the Centers for Disease Control and Prevention and the National Institute for Occupational Safety and Health, Needlestick Injuries remain a significant occupational hazard for healthcare workers. The precise number of injuries varies by study and reporting method, but published research has estimated hundreds of thousands of needlestick and other percutaneous injuries among U.S. healthcare workers annually. Safety-engineered needles, needleless systems, appropriate sharps containers, and staff training are therefore important components of a responsible procurement program.

How Hospitals Select a Supplier

Clinical and laboratory compatibility

The first question is whether the product works correctly within the hospital’s clinical and laboratory systems. Tube additives, fill ratios, clot activators, gel barriers, materials, and dimensions can affect test performance. Coagulation testing is particularly sensitive to the blood-to-Anticoagulant ratio, while hematology testing depends on correct mixing and adequate fill volume.

Hospitals should conduct formal evaluations before changing a major collection system. The evaluation may include parallel testing, specimen stability assessment, analyzer comparison, hemolysis monitoring, staff usability review, and measurement of Specimen Rejection rates. The laboratory director or designated medical staff should approve the change when the product could affect test quality.

Total cost of ownership

Unit price is only one part of the cost. A less expensive tube may create additional expenses if it requires new holders, different labels, extra staff training, manual processing, or analyzer modifications. A product that increases redraws or rejected specimens can be more expensive than a higher-priced product with better performance.

A total-cost analysis should consider product price, freight, storage space, inventory carrying costs, disposal, labor, training, equipment compatibility, implementation, waste, and clinical consequences. The hospital should also examine whether the supplier offers rebates, volume tiers, freight allowances, or committed-use pricing.

Supply continuity

The Covid-19 pandemic demonstrated how quickly global medical-supply chains can become constrained. Blood collection tubes, personal protective equipment, swabs, transport media, and other consumables experienced shortages or allocation during the pandemic. Hospitals now place greater emphasis on dual sourcing, safety stock, domestic manufacturing capacity, and transparent allocation policies.

Important questions include whether the supplier has multiple manufacturing sites, how much inventory is held in the United States, how it prioritizes customers during shortages, and whether it can provide equivalent substitute products. Hospitals should establish shortage communication procedures before a disruption occurs.

Inventory and delivery performance

Suppliers are often evaluated using fill rate, on-time delivery, order accuracy, back-order frequency, and average lead time. A hospital may set minimum performance expectations in its contract. Barcode scanning, electronic data interchange, automated replenishment, and usage dashboards can help reduce stockouts and excess inventory.

Hospitals should maintain appropriate par levels for routine items and higher safety stock for critical products with limited alternatives. However, overstocking can create expiration losses, especially for products with short shelf lives or frequent packaging changes. First-expire, first-out inventory rotation is a basic but important control.

Contracting and Purchasing Strategies

Hospitals commonly buy phlebotomy products through a combination of GPO contracts, local agreements, direct manufacturer contracts, and distributor catalogs. A GPO contract may provide attractive pricing, but the hospital should verify the contract’s actual net price after freight, fees, rebates, minimum commitments, and distributor markups.

Large health systems may negotiate enterprise agreements that standardize products across multiple hospitals. Standardization can reduce the number of products kept in stock and simplify training. It may also improve negotiating leverage. However, a system-wide standard should allow exceptions for specialty laboratories, pediatric services, oncology units, emergency departments, and transfusion services when clinical needs differ.

Hospitals should define responsibilities clearly. The manufacturer may be responsible for product specifications and technical support, while the distributor manages ordering and delivery. The contract should address product changes, back orders, recalls, damaged shipments, temperature excursions where relevant, expiration-date requirements, and liability for defective products.

1. Identify annual usage by product, department, location, and clinical application.
2. Separate routine products from critical or specialized products that require additional validation.
3. Compare at least two qualified suppliers when practical, including a primary and contingency source.
4. Request samples and conduct a documented clinical and laboratory evaluation.
5. Calculate total cost, including implementation, training, freight, storage, and potential redraws.
6. Review quality systems, regulatory status, recall history, and customer-service performance.
7. Negotiate service levels for fill rate, delivery time, shortage notification, and emergency orders.
8. Monitor supplier performance after implementation and conduct periodic contract reviews.

Questions to Ask Potential Suppliers

A hospital should ask each potential supplier for product-specific and company-wide information. The answers can reveal whether the supplier is equipped to support a complex clinical environment.

1. What FDA regulatory status applies to each product, and is the intended use clearly documented?
2. Where are the products manufactured, packaged, and distributed?
3. What is the normal lead time, and what inventory is maintained in U.S. distribution centers?
4. What is the supplier’s recent fill rate and average back-order duration?
5. How are recalls, field corrections, product complaints, and lot-specific issues communicated?
6. Are equivalent products available if the primary item is allocated or discontinued?
7. What expiration dating can the supplier guarantee at delivery?
8. Does the product work with the hospital’s analyzers, automation lines, barcode systems, and pneumatic tube network?
9. What implementation training and technical support are included?
10. What data can the supplier provide for usage, spending, delivery, and inventory analysis?

Industry Trends Affecting Phlebotomy Purchasing

Several trends are influencing how U.S. hospitals purchase blood collection products. One is the continued expansion of outpatient care. The American Hospital Association and other healthcare analysts have documented long-term growth in outpatient services, ambulatory surgery, urgent care, and hospital-affiliated clinics. This increases demand for compact, standardized, and easy-to-use collection systems outside the traditional inpatient laboratory.

Another trend is the growth of automation and barcode-based identification. The World Health Organization has emphasized that errors in the preanalytical phase can significantly affect laboratory quality. Patient identification, specimen labeling, transport, centrifugation, and accessioning are all areas where hospitals are investing in Workflow controls. Suppliers that provide compatible labels, collection devices, and automation accessories may be preferred over companies that offer tubes alone.

Needlestick prevention remains a continuing priority. Safety-engineered devices may have a higher purchase price than conventional products, but they can reduce occupational exposure risk, reporting requirements, employee treatment costs, and disruption following an injury. Hospitals should assess safety performance through staff feedback, injury reports, activation reliability, and compliance with Proper Disposal procedures.

Sustainability is also becoming more relevant. Hospitals are asking suppliers about packaging reduction, recycled materials, product take-back programs, energy use, transportation emissions, and waste segregation. Blood collection products are often disposable for infection-control reasons, so sustainability decisions must be balanced with sterility, safety, and regulatory requirements.

Which Supplier Is Best for a Hospital?

There is no single best supplier for every U.S. hospital. BD may be attractive to facilities seeking a broad, established blood collection portfolio. Greiner Bio-One and Sarstedt may provide competitive alternatives for evacuated tubes and preanalytical systems. Terumo Blood and Cell Technologies is particularly relevant to blood centers and transfusion services. FL Medical and other specialty manufacturers may offer additional sources for routine or specialized products.

Cardinal Health, McKesson, Medline, Owens & Minor, and Fisher Scientific can simplify purchasing by combining phlebotomy supplies with larger medical-surgical or laboratory orders. A regional distributor may be valuable for local responsiveness and emergency deliveries. In many cases, the most resilient model is not to choose one company for every item but to create a qualified supplier portfolio with a primary source, an approved alternative, and a documented shortage plan.

The final decision should be based on clinical suitability, regulatory compliance, supply reliability, service quality, total cost, and the hospital’s ability to validate and implement the product. Procurement, laboratory leadership, nursing, infection prevention, occupational health, finance, and frontline phlebotomists should all participate in major blood collection purchasing decisions.

Conclusion

Hospitals in the United States obtain phlebotomy and blood collection products from a mixture of major manufacturers and distribution companies. BD, Greiner Bio-One, Sarstedt, Terumo Blood and Cell Technologies, and FL Medical are among the important manufacturers, while Cardinal Health, McKesson, Medline, Owens & Minor, and Fisher Scientific are prominent distributors and supply-chain partners. Other companies serve specialized areas such as Blood Culture collection, capillary testing, transfusion medicine, specimen transport, and laboratory automation.

Because phlebotomy products directly affect patient identification, specimen quality, worker safety, and laboratory turnaround time, purchasing decisions should not be based solely on price. Hospitals should evaluate compatibility, regulatory documentation, product performance, supplier fill rates, emergency support, and total cost of ownership. A carefully managed combination of national contracts, validated alternatives, distributor support, and contingency inventory can help hospitals maintain reliable blood collection operations even when healthcare supply chains are under pressure.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos